Anastrozole: tested in a combination
122 studies: another drug in the study is under test too. Page 1 of 2. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.
- Chemotherapy Exemption in Elderly Women With Node-Positive ER+/HER2- Breast CancerNot yet recruitingNCT07826052Phase 2How we knowReport a problem
- Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in MalesRecruitingNCT07604272Phase 1How we knowReport a problem
- A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast CancerRecruitingNCT07483307Phase 2How we knowReport a problem
- De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority TrialNot yet recruitingNCT07153757Phase 3How we knowReport a problem
- Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer PatientsRecruitingNCT07071038Phase 2How we knowReport a problem
- Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast CancerNot yet recruitingNCT07005557Phase 3How we knowReport a problem
- ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast CancerRecruitingNCT06970912Phase 2How we knowReport a problem
- Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel)RecruitingNCT06656624Phase 2How we knowReport a problem
- Pre-Operative Window of ET to Inform RT Decisions (POWER II)RecruitingNCT06507618Phase 3How we knowReport a problem
- Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast CancerRecruitingNCT06361940Phase 2How we knowReport a problem
- Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast CancerNot yet recruitingNCT06223698Phase 3How we knowReport a problem
- DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as TreatmentRecruitingNCT06075953Phase 2How we knowReport a problem
- Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)RecruitingNCT05861830Phase 3How we knowReport a problem
- Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter SyndromeRecruitingNCT05586802Phase 3How we knowReport a problem
- Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast CancerRecruitingNCT05524584Phase 2How we knowReport a problem
- ETHAN - ET for Male BCRecruitingNCT05501704Phase 2How we knowReport a problem
- Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low RiskRecruitingNCT05297617Phase 2How we knowReport a problem
- Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in SituRecruitingNCT04666961Phase 2How we knowReport a problem
- Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast CancerRecruitingNCT04553770Phase 2How we knowReport a problem
- Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast CancerRecruitingNCT04023292Phase 2How we knowReport a problem
- Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)RecruitingNCT03624244Phase 2How we knowReport a problem
- Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence ScoreRecruitingNCT02476786Phase 2How we knowReport a problem
- Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial CancerCompletedNCT04719273Phase 2Results postedHow we knowReport a problem
- Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast CancerCompletedNCT04294225Phase 2Results postedHow we knowReport a problem
- Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast CancerActive, not recruitingNCT04272801Phase 2Results postedHow we knowReport a problem
- Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile FunctionCompletedNCT03933618Phase 2Results postedHow we knowReport a problem
- Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast CancerCompletedNCT03839823Phase 2Results postedHow we knowReport a problem
- Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast CancerCompletedNCT03219476Phase 2Results postedHow we knowReport a problem
- A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast CancerCompletedNCT02441946Phase 2Results postedHow we knowReport a problem
- Endocrine Response in Women With Invasive Lobular Breast CancerCompletedNCT02206984Phase 2Results postedHow we knowReport a problem
- Bay98-7196, Dose Finding / POC StudyCompletedNCT02203331Phase 2Results postedHow we knowReport a problem
- ER Reactivation Therapy for Breast CancerCompletedNCT02188745Phase 2Results postedHow we knowReport a problem
- S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast CancerTerminatedNCT02137837Phase 3Results postedHow we knowReport a problem
- Aromatase Inhibitor Growth Study: Letrozole vs. AnastrozoleCompletedNCT02137538Phase 4Results postedHow we knowReport a problem
- GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese PatientsTerminatedNCT02095184Not applicableResults postedHow we knowReport a problem
- To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid CancerCompletedNCT02093351Phase 1Results postedHow we knowReport a problem
- Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast CancerTerminatedNCT01394211Phase 2Results postedHow we knowReport a problem
- Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast CancerTerminatedNCT01368263Phase 2Results postedHow we knowReport a problem
- Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short StatureCompletedNCT01248416Phase 3Results postedHow we knowReport a problem
- Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by SurgeryTerminatedNCT01234532Phase 2Results postedHow we knowReport a problem
- ITT4 Intratesticular Hormonal Milieu in Man (ITT4)CompletedNCT01215292Phase 1/2Results postedHow we knowReport a problem
- Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung CancerTerminatedNCT00932152Phase 2Results postedHow we knowReport a problem
- Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.CompletedNCT00921115Phase 2Results postedHow we knowReport a problem
- CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in MenCompletedNCT00729859Phase 2Results postedHow we knowReport a problem
- Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine TherapyTerminatedNCT00661531Phase 2Results postedHow we knowReport a problem
- Flaxseed, Aromatase Inhibitors and Breast Tumor CharacteristicsCompletedNCT00612560Not applicableResults postedHow we knowReport a problem
- Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast CancerCompletedNCT00354640Phase 2Results postedHow we knowReport a problem
- Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic AcidCompletedNCT00295646Phase 3Results postedHow we knowReport a problem
- Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast CancerCompletedNCT00265759Phase 3Results postedHow we knowReport a problem
- Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast CancerCompletedNCT00259090Phase 2Results postedHow we knowReport a problem
- Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase InhibitorsCompletedNCT00253422Phase 3Results postedHow we knowReport a problem
- Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory DysfunctionCompletedNCT00213148Phase 2Results postedHow we knowReport a problem
- Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal WomenCompletedNCT00186121Phase 2Results postedHow we knowReport a problem
- Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.CompletedNCT00104572Phase 2Results postedHow we knowReport a problem
- Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]CompletedNCT00094328Phase 2Results postedHow we knowReport a problem
- Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In SituCompletedNCT00072462Phase 3Results postedHow we knowReport a problem
- Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast CancerCompletedNCT00057941Phase 2Results postedHow we knowReport a problem
- SMMART Adaptive Clinical Treatment (ACT) TrialWithdrawnNCT05238831Early Phase 1How we knowReport a problem
- Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast CancerCompletedNCT05150652Phase 2How we knowReport a problem
- Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers.CompletedNCT04757532Phase 1How we knowReport a problem
- A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast CancerActive, not recruitingNCT04569747Phase 2How we knowReport a problem
- Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)Active, not recruitingNCT04383275Phase 2How we knowReport a problem
- Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast CancerCompletedNCT04352777Phase 2How we knowReport a problem
- Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)TerminatedNCT04227327Phase 2How we knowReport a problem
- Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast CancerActive, not recruitingNCT04158362Phase 3How we knowReport a problem
- Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)CompletedNCT03948568Phase 4How we knowReport a problem
- Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in AdenomyosisActive, not recruitingNCT03421639Phase 4How we knowReport a problem
- A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and AnastrozoleCompletedNCT03314298Phase 1How we knowReport a problem
- Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic BreastActive, not recruitingNCT03304080Phase 1/2How we knowReport a problem
- Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer PatientsCompletedNCT03272477Phase 2How we knowReport a problem
- Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast DensityCompletedNCT03264651Phase 1How we knowReport a problem
- Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast CancerWithdrawnNCT03238703Phase 4How we knowReport a problem
- The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast CancersStatus unknownNCT03211572Phase 2How we knowReport a problem
- Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast CancerStatus unknownNCT03204734Phase 2How we knowReport a problem
- Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer PatientsCompletedNCT02995772Phase 3How we knowReport a problem
- Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast CancerActive, not recruitingNCT02942355Phase 2How we knowReport a problem
- CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast CancerActive, not recruitingNCT02918084Phase 3How we knowReport a problem
- Cardiovascular Outcomes of Low TestosteroneCompletedNCT02758431Not applicableHow we knowReport a problem
- Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node MetastasesActive, not recruitingNCT02603679Phase 2How we knowReport a problem
- Effect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal RingCompletedNCT02545452Phase 1How we knowReport a problem
- Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer PatientsTerminatedNCT02532400Phase 3How we knowReport a problem
- Detect V / CHEVENDO (Chemo vs. Endo)Active, not recruitingNCT02344472Phase 3How we knowReport a problem
- Trial of Perioperative Endocrine Therapy - Individualising CareActive, not recruitingNCT02338310Phase 3How we knowReport a problem
- Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast CancerStatus unknownNCT02097459Phase 3How we knowReport a problem
- Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast CancerStatus unknownNCT02089854Phase 4How we knowReport a problem
- Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast CancerCompletedNCT01989780Phase 2How we knowReport a problem
- Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryActive, not recruitingNCT01953588Phase 3How we knowReport a problem
- Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast CancerCompletedNCT01950182Phase 3How we knowReport a problem
- Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast CancerStatus unknownNCT01924078Phase 2How we knowReport a problem
- Impact of Estradiol AddbackCompletedNCT01862835Phase 1How we knowReport a problem
- Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast CancerCompletedNCT01612871Phase 4How we knowReport a problem
- Adjuvant AI Combined With ZoladexStatus unknownNCT01352091Phase 3How we knowReport a problem
- Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal WomenStatus unknownNCT01266213Phase 2How we knowReport a problem
- Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast CancerTerminatedNCT01262274Phase 2How we knowReport a problem
- Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome ResistanceCompletedNCT01197170Phase 1How we knowReport a problem
- Bioequivalence Study of Anastrozole 1 mg TabletCompletedNCT01105299Not applicableHow we knowReport a problem
- Metabolic Effects of Steroids in Obese MenStatus unknownNCT00983554Not applicableHow we knowReport a problem
- Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)CompletedNCT00944918Phase 3How we knowReport a problem
- Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast CancerCompletedNCT00893061Phase 3How we knowReport a problem
- ATAC - Arimidex, Tamoxifen Alone or in CombinationCompletedNCT00849030Phase 3How we knowReport a problem